CClinicalTrials.gg
CompletedNCT05146531Updated Dec 6, 2021

Comparison of McCoy Laryngoscope and C-MAC D-blade Video Laryngoscope in Obese Patients

An interventional study of McCoy laryngoscope and C-MAC D-blade video laryngoscope in Obesity, sponsored by Eun Young Park. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-12-06.

Sponsored by Eun Young Park · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Dec 2019, registered Nov 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
104
Allocation
Randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

Obesity is associated with difficult intubation rate of 30%, and this study was performed to compare the use of McCoy laryngoscope and C-MAC D-blade video laryngoscope for intubation in obese patients. A total 104 patients with body mass index (BMI) ≥ 35kg/m² scheduled for general anesthesia were randomly assigned to be intubated with McCoy laryngoscope or C-MAC D-blade video laryngoscope. The primary outcome was intubation time, and secondary outcomes were mask ventilation scale, intubation difficulty scale (IDS), percentage of glottis opening (POGO) score, and hemodynamic variables including mean arterial pressure, heart rate and saturation.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • obesity
  • intubation
  • laryngoscopes
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 104 is above the median of 78 across 4,878 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

This is the only study on the registry with Eun Young Park as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • American society of anesthesiologists physical status of I-II patients with BMI ≥ 35 kg/m² scheduled for general anesthesia

Exclusion criteria

Exclusion Criteria:

  • patients with tracheal diseases, sore throat, neck pain and loose tooth.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
104 participants (actual)

Study arms

  • Active comparator
    McCoy group

    Patients were intubated with McCoy laryngoscope.

    Device: McCoy laryngoscope

  • Experimental
    C-MAC group

    Patients were intubated with C-MAC D-blade video laryngoscope.

    Device: C-MAC D-blade video laryngoscope

Interventions

  • DeviceMcCoy laryngoscope

    Patients scheduled for general anesthesia were intubated with McCoy laryngoscope.

  • DeviceC-MAC D-blade video laryngoscope

    Patients scheduled for general anesthesia were intubated with C-MAC D-blade video laryngoscope.

06

What researchers measure

Primary outcomes

  1. Intubation time

    Timing measurement began when the laryngoscope blade was inserted in patients' mouth and ended when end tidal carbon dioxide tracing was detected in the monitor.

    Time frame: The patients were excluded in this study if intubation time was over 90 seconds.

07

Study locations

1 site
  • Hallym university sacred heart hospital
    Anyang-si, Gyeonggi-do 14066, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05146531
Lead sponsor
Eun Young Park
Responsible party
Eun Young Park (Associate professor, Hallym University Medical Center) — Sponsor-investigator
First posted
Dec 6, 2021
Start date
Dec 6, 2019
Primary completion
Aug 5, 2021
Completion
Aug 5, 2021
Last update
Dec 6, 2021

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion